Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Giovanni Battista Rossi is active.

Publication


Featured researches published by Giovanni Battista Rossi.


European Journal of Human Genetics | 1999

Three submicroscopic deletions at the APC locus and their rapid detection by quantitative-PCR analysis.

Marina De Rosa; Maria I. Scarano; Luigi Panariello; Nicola Carlomagno; Giovanni Battista Rossi; Alfonso Tempesta; Patrizia Borgheresi; Andrea Renda; Paola Izzo

We describe three unrelated kindreds, affected by familial adenomatous polyposis (FAP), with 5q submicroscopic deletions that encompass the entire adenomatous polyposis coli (APC) gene and the adjacent DP1 gene. In one family the deletion encompasses also the MCC (mutated in colon cancer) gene. Affected members of these families had dysplastic adenomatous polyps and congenital hypertrophy of the retinal pigment epithelium (CHRPE); no individual was affected by mental retardation or facial dysmorphism. The deletions were detected by linkage analysis with several intragenic and closely flanking polymorphic markers and confirmed by a quantitative PCR analysis. This procedure could have an impact on the detection of the molecular defect in FAP patients in whom mutational analysis fails to identify the specific mutation.


Applied Immunohistochemistry & Molecular Morphology | 2008

Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA)

Giovanni Ponti; Lorena Losi; Giovanni Pellacani; Giovanni Battista Rossi; Livio Presutti; Francesco Mattioli; Domenico Villari; Luciano Wannesson; Matteo Alicandri Ciufelli; Paola Izzo; Marina De Rosa; Pietro Marone; Stefania Seidenari

Juvenile nasopharyngeal angiofibroma (JNA) is a rare, invasive, and locally destructive tumor of the nasopharynx. The Wnt pathway, angiogenetic and hormonal factors are involved in the pathophysiology of JNA; it can result in an extracolonic manifestation of familial adenomatous polyposis (FAP) or in a sporadic tumor. All patients who underwent resection of JNA between 1991 and 2006 at the University of Modena and Reggio Emilia were studied to identify immunohistochemical markers of associated FAP syndrome. Paraffin-embedded JNA samples were analyzed immunohistochemically for the expression of adenomatous polyposis coli (APC), β-catenin, E-cadherin, androgen receptor, and vascular endothelial growth factors receptor (VEGFR2). In one out of the 4 (25%) young patients affected by JNA the diagnosis of FAP syndrome linked to APC mutation was made. All of the sporadic and familial JNA tumors showed nuclear staining of β-catenin, whereas altered APC expression was seen only in FAP-associated JNA. All cases were stained with VEGFR2. A combined clinical, immunohistochemical, and biomolecular screening may be useful for the identification of FAP among patients with a diagnosis of JNA. The Wnt pathway can be involved in the JNA pathogenesis either by somatic mutations of β-catenin or by germline APC mutations. As the VEGFR has an important impact on the pathogenesis of JNA, we suggest that a targeted therapy with monoclonal antibodies against VEGFR might lead to a specific chemoprevention and treatment of these tumors and their recurrences.


World Journal of Gastroenterology | 2013

Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis

Martina Galatola; Erasmo Miele; Caterina Strisciuglio; Lorella Paparo; Daniela Rega; Paolo Delrio; Francesca Duraturo; Massimo Martinelli; Giovanni Battista Rossi; Annamaria Staiano; Paola Izzo; Marina De Rosa

AIMnTo investigated the molecular cause of very early-onset ulcerative colitis (UC) in an 18-mo-old affected child.nnnMETHODSnWe analysed the interleukin-10 (IL10) receptor genes at the DNA and RNA level in the proband and his relatives. Beta catenin and tumor necrosis factor-α (TNFα) receptors were analysed in the proteins extracted from peripheral blood cells of the proband, his relatives and familial adenomatous polyposis (FAP) and PTEN hamartoma tumor syndrome (PHTS) patients. Samples were also collected from the probands inflamed colorectal mucosa and compared to healthy and tumour mucosa collected from a FAP patient and patients affected by sporadic colorectal cancer (CRC). Finally, we examined mesalazine and azathioprine effects on primary fibroblasts stabilised from UC and FAP patients.nnnRESULTSnOur patient was a compound heterozygote for the IL10RB E47K polymorphism, inherited from his father, and for a novel point mutation within the IL10RA promoter (the -413G->T), inherited from his mother. Beta catenin and tumour necrosis factor α receptors-I (TNFRI) protein were both over-expressed in peripheral blood cells of the probands relatives more than the proband. However, TNFRII was over-expressed only in the proband. Finally, both TNFα-receptors were shown to be under-expressed in the inflamed colon mucosa and colorectal cancer tissue compared to healthy colon mucosa. Consistent with this observation, mesalazine and azathioprine induced, in primary fibroblasts, IL10RB and TNFRII over-expression and TNFRI and TNFα under-expression. We suggest that β-catenin and TNFRI protein expression in peripheral blood cells could represent molecular markers of sub-clinical disease in apparently healthy relatives of patients with early-onset UC.nnnCONCLUSIONnA synergistic effect of several variant alleles of the IL10 receptor genes, inherited in a Mendelian manner, is involved in UC onset in this young child.


Human Mutation | 1999

Familial Adenomatous Polyposis Coli: Five Novel Mutations in Exon 15 of the Adenomatous Polyposis Coli (APC) Gene in Italian Patients

Maria I. Scarano; Marina De Rosa; Luigi Panariello; Nicola Carlomagno; G. Riegler; Giovanni Battista Rossi; Luigi Bucci; Giuseppe Pesce; Federico Toni; Andrea Renda; Paola Izzo

Germline mutations within the adenomatous polyposis coli (APC) gene, a tumor suppressor gene, are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date, more than 300 germ‐line causative mutations within this gene have been described (Beroud and Soussi, 1996). Of these, about 95% are chain‐terminating mutations, and more than 60% have been localized within exon 15 (Nagase and Nakamura, 1993, Beroud and Soussi, 1996). Using polymerase chain reaction‐single strand conformation polymorphism, protein truncation test (PTT) and DNA sequencing we have identified five new frameshift mutations (2523insCTTA, 2638delA, 2803insA, 3185delAA, 4145delTCATGT), all occurring within exon 15 and giving rise to truncated protein products. Two of these new mutations are of particular interest because of the unusual phenotypic features shown by probands. The phenotype of the proband bearing the 2523insCTTA mutation at codon 842 was very aggressive with onset of the symptoms at 12 years, while the patient bearing the 3185delAA mutation at codon 1062 exhibited features of an attenuated form of FAP (AAPC). Our data reiterate the great heterogeneity of the mutational spectrum in FAP that gives rise to an extreme variability of the clinical expression.


BMC Medical Genetics | 2012

Beta catenin and cytokine pathway dysregulation in patients with manifestations of the "PTEN hamartoma tumor syndrome"

Martina Galatola; Lorella Paparo; Francesca Duraturo; Mimmo Turano; Giovanni Battista Rossi; Paola Izzo; Marina De Rosa

BackgroundThe PTEN hamartoma tumor syndrome (PHTS) includes a group of syndromes caused by germline mutations within the tumor suppressor gene phosphatase and tensin homolog deleted on chromosome ten (PTEN), characterized by multiple polyps in the gastrointestinal tract and by a highly increased risk of developing malignant tumours in many tissues.The current work clarifies the molecular basis of PHTS in three unrelated Italian patients, and sheds light on molecular pathway disregulation constitutively associated to PTEN alteration.MethodsWe performed a combination of RT-PCR, PCR, sequencing of the amplified fragments, Real Time PCR and western blot techniques.ResultsOur data provide the first evidence of β-catenin accumulation in blood cells of patients with hereditary cancer syndrome caused by germ-line PTEN alteration. In addition, for the first time we show, in all PHTS patients analysed, alterations in the expression of TNFα, its receptors and IL-10. Importantly, the isoform of TNFRI that lacks the DEATH domain (TNFRSF1β) was found to be overexpressed.ConclusionIn light of our findings, we suggest that the PTEN pathway disregulation could determine, in non-neoplastic cells of PHTS patients, cell survival and pro-inflammatory stimulation, mediated by the expression of molecules such as β-catenin, TNFα and TNFα receptors, which could predispose these patients to the development of multiple cancers.


International Journal of Oncology | 2015

Lithium chloride induces mesenchymal‑to‑epithelial reverting transition in primary colon cancer cell cultures

Valeria Costabile; Francesca Duraturo; Paolo Delrio; Daniela Rega; Ugo Pace; Raffaella Liccardo; Giovanni Battista Rossi; Rita Genesio; Lucio Nitsch; Paola Izzo; Marina De Rosa

Epithelial-to-mesenchymal transition (EMT) confers stem cell-like phenotype and more motile properties to carcinoma cells. During EMT, the expression of E-cadherin decreases, resulting in loss of cell-cell adhesion and increased migration. Expression of Twist1 and other pleiotropic transcription factors, such as Snail, is known to activate EMT. We established primary colon cancer cell cultures from samples of operated patients and validated cultures by cytogenetic and molecular biology approaches. Western blot assay, quantitative real-time PCR and immunofluorescence were performed to investigate the expression of E-cadherin, vimentin, β-catenin, cytokeratin-20 and -18, Twist1, Snail, CD44, cyclooxygenase-2 (COX2), Sox2, Oct4 and Nanog. Moreover, cell differentiation was induced by incubation with LiCl-containing medium for 10 days. We observed that these primary colorectal cancer (CRC) cells lost expression of the E-cadherin epithelial marker, which was instead expressed in cancer and normal colon mucosa of the same patient, while overexpressed vimentin (mesenchymal marker), Twist1, Snail (EMT markers) and COX2. Cytokeratin-18 was expressed both in tissues and cell cultures. Expression of stem cell markers, such as CD44, Oct4 and Nanog, were also observed. Following differentiation with the glycogen synthase kinase 3β (GSK3β) inhibitor LiCl, the cells began to express E-cadherin and, at once, Twist1 and Snail expression was strongly downregulated, suggesting a MET-reverting process. In conclusion, we established primary colon mesenchymal cancer cell cultures expressing mesenchymal and epithelial biomarkers together with high level of EMT transcription factors. We propose that they could represent a good model for studying EMT and its reverting mechanism, the mesenchymal-to-epithelial transition (MET). Our observation indicates that LiCl, a GSK3β inhibitor, induces MET in vitro, suggesting that LiCl and GSK3β could represent, respectively, interesting drug, and target for CRC therapy.


Diseases of The Colon & Rectum | 2001

Phenotype-genotype correlations in an extended family with adenomatosis coli and an unusual APC gene mutation.

Maurizio Ponz de Leon; Liliana Varesco; Piero Benatti; Romano Sassatelli; Paola Izzo; Maria I. Scarano; Giovanni Battista Rossi; Carmela Di Gregorio; Viviana Gismondi; Antonio Percesepe; Marina De Rosa; Luca Roncucci

PURPOSE: Genotype-phenotype correlations in familial adenomatous polyposis are only partially understood and, in particular, little is known about the biomolecular characteristics of desmoid tumors, which are one of the most serious and frequent manifestations of familial adenomatous polyposis. In the present study, we describe a family with familial adenomatous polyposis, with peculiar clinical characteristics (i.e., frequency and severity of desmoid neoplasms) associated with an unusual mutation of the adenomatosis polyposis coli gene. If confirmed by other investigations, these findings might help to understand the biologic mechanisms by which specific adenomatosis polyposis coli mutations predispose to desmoid tumors. METHODS: The family with familial adenomatous polyposis, living in southern Italy, was studied from 1985 to the end of 1999; at this date, 15 individuals have been affected by histologically verified familial adenomatous polyposis, 11 of whom had desmoid tumors. A total of 19 family members were studied for adenomatosis polyposis coli gene mutations; 13 of them tested positive and 6 negative. The analytical procedure—previously described—consisted of the extraction of peripheral blood cell DNA, amplification of exon 15 by polymerase chain reaction, single-strand conformation polymorphism analysis, and direct sequencing of the DNA fragment containing the mutation. RESULTS: The main clinical features of the family were 1) a high frequency of desmoid tumors and, consequently, a high penetrance of the desmoid trait in all branches of the family and in 11 (73.3 percent) of 15 affected individuals and 2) severity of desmoids in at least 4 family members, 2 of whom died for causes related to the presence of these tumors. The molecular basis of the disease was an uncommon mutation of the adenomatosis polyposis coli gene, consisting of a large deletion of 310 base pairs at codon 1,464, with duplication of the breakpoint (4,394ins15del310), leading to a stop codon at position 1,575. CONCLUSIONS: The present study shows that a truncating mutation in the adenomatosis polyposis coli gene at the beginning of the region frequently associated with desmoids induced a familial adenomatous polyposis phenotype featured by a high penetrance of the desmoid trait, with severe disease in several affected members of both sexes. The study may help to understand the biologic mechanisms of genotype-phenotype correlations in adenomatosis coli.


Gene | 2007

Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript

Marina De Rosa; Gemma Morelli; Elena Cesaro; Francesca Duraturo; Mimmo Turano; Giovanni Battista Rossi; Paolo Delrio; Paola Izzo


Gastroenterology | 2010

Alu-mediated genomic deletion of the serine/threonine protein kinase 11 (STK11) gene in Peutz-Jeghers syndrome.

Marina De Rosa; Martina Galatola; L. Quaglietta; Erasmo Miele; Giovanni De Palma; Giovanni Battista Rossi; Annamaria Staiano; Paola Izzo


Diseases of The Colon & Rectum | 2007

Identification and Classification of Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Adapting Old Concepts to Recent Advancements. Report from the Italian Association for the Study of Hereditary Colorectal Tumors Consensus Group

Maurizio Ponz de Leon; Lucio Bertario; Maurizio Genuardi; Giovanni Lanza; Cristina Oliani; Guglielmina Nadia Ranzani; Giovanni Battista Rossi; Liliana Varesco; Tiziana Venesio; Alessandra Viel

Collaboration


Dive into the Giovanni Battista Rossi's collaboration.

Top Co-Authors

Avatar

Marina De Rosa

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Paola Izzo

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Francesca Duraturo

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Maria I. Scarano

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Andrea Renda

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Luigi Panariello

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Martina Galatola

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Nicola Carlomagno

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Annamaria Staiano

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Erasmo Miele

University of Naples Federico II

View shared research outputs
Researchain Logo
Decentralizing Knowledge